SEC Form 4 · accession 0001562180-18-003092
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bernard Birkett
Officer — Sr VP, CFO & Treasurer
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 21, 2018 | A | 9,908 | $0.00 | A | 9,908 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2 | $100.92 | Jun 21, 2018 | A | 13,884 | A | Jun 21, 2019 | Jun 21, 2028 | Common Stock | 13,884 | 13,884 | D |
Explanation of responses
- F1This award vests over four years starting on the first anniversary date of the award.
- F2This award vests in four equal annual installments beginning on June 21, 2019.